Zhang, W.; Lu, J.; Wang, Y.; Sun, P.; Gao, T.; Xu, N.; Zhang, Y.; Xie, W.
Canagliflozin Attenuates Lipotoxicity in Cardiomyocytes by Inhibiting Inflammation and Ferroptosis through Activating AMPK Pathway. Int. J. Mol. Sci. 2023, 24, 858.
https://doi.org/10.3390/ijms24010858
AMA Style
Zhang W, Lu J, Wang Y, Sun P, Gao T, Xu N, Zhang Y, Xie W.
Canagliflozin Attenuates Lipotoxicity in Cardiomyocytes by Inhibiting Inflammation and Ferroptosis through Activating AMPK Pathway. International Journal of Molecular Sciences. 2023; 24(1):858.
https://doi.org/10.3390/ijms24010858
Chicago/Turabian Style
Zhang, Wanqiu, Jinghua Lu, Yangyang Wang, Pengbo Sun, Tong Gao, Naihan Xu, Yaou Zhang, and Weidong Xie.
2023. "Canagliflozin Attenuates Lipotoxicity in Cardiomyocytes by Inhibiting Inflammation and Ferroptosis through Activating AMPK Pathway" International Journal of Molecular Sciences 24, no. 1: 858.
https://doi.org/10.3390/ijms24010858
APA Style
Zhang, W., Lu, J., Wang, Y., Sun, P., Gao, T., Xu, N., Zhang, Y., & Xie, W.
(2023). Canagliflozin Attenuates Lipotoxicity in Cardiomyocytes by Inhibiting Inflammation and Ferroptosis through Activating AMPK Pathway. International Journal of Molecular Sciences, 24(1), 858.
https://doi.org/10.3390/ijms24010858